Publications

Publications

Filter Results: (925) Arrow Down
Filter Results: (925) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 17 of 925 Results →
  • 11 Sep 2007
  • First Look

First Look: September 11, 2007

Limited was facing significant pricing pressure in their cash cow business, that primarily consisted of manufacturing Active Pharmaceutical Ingredients (APIs). To combat this commoditization, Biocon's leadership had chosen an... View Details
Keywords: Martha Lagace
  • January 1998 (Revised February 2006)
  • Background Note

Creating Competitive Advantage

By: Pankaj Ghemawat and Jan W. Rivkin
A firm such as Schering-Plough that earns superior, long-run financial returns within its industry is said to enjoy a competitive advantage over its rivals. This note examines the logic of how firms create competitive advantage. It emphasizes two themes: First, to... View Details
Keywords: Competitive Advantage; Competitive Strategy; Management; Business Strategy; Growth and Development Strategy; Innovation Strategy; Management Practices and Processes; Value Creation; Pharmaceutical Industry
Related
  • October 2019
  • Supplement

Impax Laboratories: Executing Accretive Transactions (A)

By: Benjamin C. Esty and Daniel Fisher
Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the... View Details
Keywords: Financial Reporting; Financial Statements; Mergers and Acquisitions; Capital Structure; Financial Strategy; Competition; Competitive Advantage; Corporate Strategy; Pharmaceutical Industry; United States
Related
  • October 2019
  • Case

Impax Laboratories: Executing Accretive Acquisitions (A)

By: Benjamin C. Esty and Daniel Fisher
Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the... View Details
Keywords: Financial Reporting; Financial Statements; Mergers and Acquisitions; Capital Structure; Competition; Competitive Advantage; Corporate Strategy; Pharmaceutical Industry; United States
Related
  • 07 Jan 2010
  • Working Paper Summaries

International Differences in the Size and Roles of Corporate Headquarters: An Empirical Examination

Keywords: by David Collis, David Young & Michael Goold
  • March 2011 (Revised February 2012)
  • Case

Innovation and Growth at Actelion Ltd.

By: Gary P. Pisano, Daniela Beyersdorfer and Ruth Dittrich
In late 2010, Jean-Paul Clozel, CEO of the Swiss biotech pharmaceuticals firm Actelion, looks back on a successful decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven... View Details
Keywords: Business Model; Talent and Talent Management; Innovation and Management; Leadership; Growth and Development Strategy; Product Development; Organizational Culture; Research and Development; Biotechnology Industry; Biotechnology Industry; Switzerland
Related

    Roberto Verganti

    Roberto Verganti (rverganti@hbs.edu) is in the Technology and Operations Management Unit at Harvard Business School. He teaches Design Theory and Practice for the View Details

    Keywords: industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods; industrial goods
    • Web

    Strategy - Doctoral

    Strategy The doctoral program in Strategy encourages students to pursue multi-disciplinary research that utilizes multiple methodologies—quantitative, as well as qualitative—to study how companies and industries around the world develop... View Details
    • 14 Aug 2007
    • First Look

    First Look: August 14, 2007

    in West Africa, 1950-1970 Author:Stephanie Decker Periodical:Business History Review 81 (spring 2007): 59-86 Abstract Development, modernity, and industrialization became dominant themes in corporate advertising in Africa in the 1950s and... View Details
    Keywords: Martha Lagace
    • 16 Aug 2011
    • Working Paper Summaries

    Managing Political Risk in Global Business: Beiersdorf 1914-1990

    Keywords: by Geoffrey Jones & Christina Lubinski; Beauty & Cosmetics
    • June 2024 (Revised December 2024)
    • Case

    Lana Ghanem: Pushing the Boundaries of Health Care Through Venture Capital

    By: Joshua D. Margolis and Ahmed Dahawy
    Lana Ghanem, managing director of Hikma Ventures, the corporate venture arm of larger pharmaceutical group Hikma, is considering how to grow the venture arm as well as progress her own career. Over the past few years Hikma's executive team had been pressuring the... View Details
    Keywords: Business Divisions; Corporate Entrepreneurship; Investment; Corporate Governance; Health Care and Treatment; Leadership Development; Business or Company Management; Growth and Development Strategy; Business Strategy; Venture Capital; Personal Development and Career; Health Industry; Health Industry; Jordan
    Related
    • November 2017
    • Case

    The 'Wonder Drug' That Killed Babies

    By: Joshua Lev Krieger, Tom Nicholas and Matthew Preble
    In the early 1960s, a popular drug taken by patients worldwide for a range of maladies was found to cause severe birth defects and other health problems in babies born to mothers who had taken it during a certain stage of fetal development. As many as 10,000 children... View Details
    Keywords: Regulation; Business and Government Relations; Business and Community Relations; Business and Stakeholder Relations; Product Marketing; Corporate Social Responsibility and Impact; Business History; Health; Government Legislation; Corporate Accountability; Ethics; Governing Rules, Regulations, and Reforms; Pharmaceutical Industry; Pharmaceutical Industry; United States; United Kingdom; Australia; Germany; Europe
    Related
    • January 2017
    • Case

    Danaher Corporation, 2007–2017

    By: John R. Wells and Gabriel Ellsworth
    On July 2, 2016, Danaher Corporation completed the spinoff of Fortive Corporation. The previous day, Danaher’s stock price had reached an all-time high. In 2015, Danaher had decided to split off its test and measurement, fuel and fleet management, and automation... View Details
    Keywords: Danaher; Fortive; Larry Culp; Beckman Coulter; Pall; Life Sciences; Diagnostics; Environmental Operations; Water Management; Dental; Testing; Measurement; Fuel; Fleet Management; Automation; Toolmaking; Tools; Disease Management; Continuous Improvement; Toyota Production System; Divestiture; Spinoffs; Spin-off; Networks; Acquisition; Mergers and Acquisitions; Business Conglomerates; Business Divisions; Business Subsidiaries; Business Units; Business Growth and Maturation; Business Model; For-Profit Firms; Joint Ventures; Restructuring; Engineering; Chemicals; Construction; Machinery and Machining; Profit; Revenue; Globalized Firms and Management; Multinational Firms and Management; Health; Health Care and Treatment; Health Disorders; Medical Specialties; Business History; Job Cuts and Outsourcing; Business or Company Management; Growth and Development Strategy; Management Analysis, Tools, and Techniques; Management Practices and Processes; Management Succession; Management Systems; Resource Allocation; Market Entry and Exit; Measurement and Metrics; Logistics; Business Processes; Organizational Change and Adaptation; Public Ownership; Problems and Challenges; Science; Genetics; Natural Environment; Wastes and Waste Processing; Science-Based Business; Opportunities; Strategy; Adaptation; Business Strategy; Competition; Competitive Strategy; Competitive Advantage; Consolidation; Corporate Strategy; Diversification; Expansion; Technology; Software; Technology Networks; Technology Platform; Value; Valuation; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; Aerospace Industry; United States; District of Columbia
    Related
    • 07 Aug 2000
    • Research & Ideas

    The Business of Biotech

    coming of age of biotechnology. The disappearance of "blockbuster" drugs could create new management challenges for pharmaceutical companies. — Gary Pisano The prospect is exhilarating, but the road to this brave new biotech... View Details
    Keywords: by Julia Hanna; Biotechnology; Health; Technology
    • May 2021
    • Case

    The SMA Foundation: Steering Therapeutic Research and Development in a Rare Disease

    By: Amitabh Chandra, Spencer Lee-Rey and Caroline Marra
    This case explores incentives for rare disease drug development by chronicling the role of the Spinal Muscular Atrophy (SMA) Foundation in forming strategic partnerships with the scientific research community and pharmaceutical developers to transform the trajectory... View Details
    Keywords: Innovation and Invention; Strategy; Business or Company Management; Society; Health; Public Administration Industry; Public Administration Industry; United States
    Related
    • August 2023
    • Case

    Constellation Pharmaceuticals: Corporate Development at a Novel Therapeutic Company

    By: Satish Tadikonda and Brad Prosek
    Constellation Pharmaceuticals was a company focused on epigenetic therapies for cancer patients. Despite a promising start and an early deal with a leading biopharma company, the company weathered twin setbacks in the end of a major research collaboration and the... View Details
    Keywords: Mergers and Acquisitions; Health Care and Treatment; Organizational Change and Adaptation; Research and Development; Business Strategy; Partners and Partnerships; Goals and Objectives; Pharmaceutical Industry; United States
    Related
    • 15 May 2007
    • First Look

    First Look: May 15, 2007

    the industry and dominated it for nearly 20 years, the well-respected company faces a bevy of new entrants from the banking, mortgage finance, and insurance sectors. In particular, management must decide how to respond to an aggressive... View Details
    Keywords: Martha Lagace
    • Web

    Hiring Organizations

    Partners AllWin Alpaca Real Estate Alphabroder Alpine Investors Alterra Capital Partners Altitude AI Altos Ventures Alumni Ventures Amazon Amazon Web Services - AWS Ambit Partners American Express American Industrial Partners Amex... View Details

      Regina E. Herzlinger

      Regina E. Herzlinger is the Nancy R. McPherson Professor of Business Administration at the Harvard Business School. She was the first woman to be tenured and chaired at Harvard Business School and serve on many established and start-up corporate health care/medical... View Details

      Keywords: insurance industry; insurance industry; insurance industry; insurance industry; insurance industry
      • 23 Jul 2001
      • Research & Ideas

      How Relationships are Building Biotech

      How does an industry get born? To answer that question, it helps to turn the microscope on one fairly new industry: biotechnology. A still further way to get inside this question, according to HBS professor Monica C. Higgins, is to take a... View Details
      Keywords: by Martha Lagace & Mallory Stark